Talking Biotech 211 - CAR-T Cells: Engineered to Attack Cancer
This week's podcast is pure gold, a great interview with Dr. Joe Fraietta from University of Pennsylvania. Dr. Fraietta discusses CAR-T cells, human immune cells genetically engineered to attack specific cancers. It is a great primer on a new therapy that is changing cancer treatment.
